A major advantage of microfluidic devices is the ability to manipulate small sample volumes, thus reducing reagent waste and preserving precious sample. However, to achieve robust sample manipulation it is necessary to address device integration with the macroscale environment. To realize repeatable, sensitive particle separation with microfluidic devices, this protocol presents a complete automated and integrated microfluidic platform that enables precise processing of 0.15-1.5 ml samples using microfluidic devices. Important aspects of this system include modular device layout and robust fixtures resulting in reliable and flexible world to chip connections, and fully-automated fluid handling which accomplishes closed-loop sample collection, system cleaning and priming steps to ensure repeatable operation. Different microfluidic devices can be used interchangeably with this architecture. Here we incorporate an acoustofluidic device, detail its characterization, performance optimization, and demonstrate its use for size-separation of biological samples. By using real-time feedback during separation experiments, sample collection is optimized to conserve and concentrate sample. Although requiring the integration of multiple pieces of equipment, advantages of this architecture include the ability to process unknown samples with no additional system optimization, ease of device replacement, and precise, robust sample processing.
Introduction
Sample separation and fractionation is one of the most promising areas of application for microfluidic technologies. Such sample handling steps are integral for effective clinical diagnostics, therapeutics development, biosurveillance efforts, and progress in life science research and technology. A myriad microfluidic separation strategies have been demonstrated for fluid-suspended particulates and colloids, as well as for chemical and biological species; several reviews provide overviews of recent progress and developments in these fields [1] [2] [3] [4] [5] [6] [7] [8] [9] . Although many of these microfluidic separation technologies (hereafter referred to as "Core Devices") have been extensively characterized, few reports have considered the sample separation problem at a system level. The Core Devices are typically individual centimeter-scale chips, interfaced to fluoropolymer tubing, with fluid delivered by a displacement or pressure pump. Yet, if the promise of microfluidics--including increased automation, reliability, and reduction in sample volumes--is to become reality, at least an equivalent effort must be devoted to the design of a complete separation system into which the Core Device is integrated.
In addition, a major challenge for microfluidic approaches to biodetection is the macro to micro interface. This refers not only to the physical "world-to-chip" connections of a microfluidic device to macroscale components, and to the mismatch between typical clinical or analytical sample volumes (~0.1-10 ml) and the internal volume of microfluidic chips (~0.01-10 µl), but also to the statistical sampling limitations arising from bridging these size scales. These issues contribute to the perception that sample pre-processing and preparation are the "weak link" of biodetection. 10 The platform described in this work takes major steps toward addressing these challenges.
Taking a system-level view, this protocol details the reliable processing of precisely-metered analytical-scale volumes (ranging from 0.15 to 1.5 ml) on ~10-min timescales. This is a "one-button" operation: once the source vial containing the sample and destination vials for fraction collection are placed into the system, the "run" command initiates the procedure, and all steps are computer-controlled. At the end of a run, the collection vials can be removed from the system for downstream analysis of the separated fractions.
Ultrasound standing waves resonating in fluid-filled microchannels produce pressure fields, which give rise to forces that drive particles toward nodes of low pressure. The force magnitude depends on the particle's volume, and on an acoustic contrast factor derived from the relative densities and compressibilities of the particle and the suspending fluid. 14 As such, acoustic focusing is ideally suited to separation of cell-sized (~7-15 µm) from virus-sized (~50-200 nm) particles. The larger particles migrate toward a pressure node; however, since the force magnitude is very small for particles smaller than 2-3 µm, these small particles or dissolved species hardly move at all. Our specific implementation of acoustic separation, as previously described, 15 incorporates a thin wall to subdivide the fluid channel and allows tunable, asymmetric placement of the focusing position. This adds flexibility in device design, and the performance benefits-including increased separation quality and speedare fully described elsewhere. 16, 17 However, a major advantage of the system-level design approach described in this work is that it is adaptable to a great variety of microfluidic Core Devices. For example, most other continuous-flow separation modes, including inertial, flow-field fractionation, deterministic lateral displacement (DLD), and various types of electrokinetic devices can be readily incorporated, with appropriate adjustments made to account for changes in inlet/outlet configuration, flow rates, and sample volumes. Devices with various types of on-chip fields (electric, magnetic) or gradients (thermal, chemical) may require additional connections to the chip, or the integration of additional hardware, which this platform accommodates.
This protocol provides the steps required to design a microfluidic separation device, and to fabricate silicon-glass chips by deep reactive ion etching (DRIE, a plasma-etch process available in many microfabrication facilities, which uses alternating cycles of etching and passivation to achieve deep features with vertical sidewalls 18 ). Next, we describe the characterization of the acoustofluidic device to determine the optimal operating parameters for separation, and finally detail the fully-integrated separation system and the procedure for processing biological samples. Typical device characterization results and sample processing data are then presented and discussed, and the key advantages of this approach are highlighted, including modularity, robustness, precision and automation.
Protocol

Acoustophoretic Device Design and Photomask Layout
NOTE: General considerations and guidance for microfabrication process design and mask layout can be found in texts on microfabrication and tutorials of photomask design. [19] [20] [21] 1. Lay out Mask 1, the Fluidic Layer (front side), using appropriate CAD software. Choose a geometry that permits sample injection and separation appropriate for the desired application. 1. For acoustic focusing, set the fluidic channel width w to provide a resonant frequency f n greater than 1 MHz according to the equation f n = nc/2w, where c is the speed of sound in the relevant fluid and n is the number of standing-wave nodes (e.g., for a 900-µm wide channel, the two-node resonance is expected at f 2 = 1.65 MHz). NOTE: Particles occupying distinct lateral positions near the end of the separation channel should exit from distinct outlets. In this protocol, particles are separated by size, so the outlets are designated SPO and LPO, for small-particle and large-particle outlet, respectively, as shown in Figure 1 . 2. Set the fluid channel length to control the length of time particles are exposed to the separation field at a specific flow rate. Longer onchip residence time for particles to migrate due to separation forces must be traded off against the larger required chip footprint. NOTE: In our acoustic focusing devices, the flow channel makes three passes down the chip for increased residence time (Figure 2a) . At a typical total flow rate of 200 µl/min, particles flowing through the 300 x 200 µm cross-section, 117-mm long separation channel spend on average 2.1 sec in the acoustic field. 2. Device Mounting and World-To-Chip Interfacing 1. Attach the chip to the "fluidic breadboard" (a plate with a grid of regularly-spaced threaded through-holes) using clamping fixtures. Attach a cooling fan to the breadboard to regulate temperature during acoustic experiments (see Figure 2) . NOTE: Operating without the cooling fan at typical drive voltages raises the device temperature to 70-80 °C. This significantly shifts the resonant frequency due to altered sound velocity in the fluid, and may negatively impact the viability of any biological particles that are being processed. 2. Screw in chip-to-world connectors, previously described elsewhere 22 and shown in Figure 2 . Join these interface tubes to additional tubing at the inlets and outlets using standard ¼"-28 unions for 1/16" tubing.
Cleanroom Fabrication of Microfluidic Chips for Acoustophoresis
Characterization of Acoustic Focusing Performance
NOTE: System components required for acoustic focusing characterization are grouped together in the Materials List. Steps 4.1 and 4.2 below apply to any Core Device used with this platform, whereas subsequent steps describe operations specific to the acoustofluidic device discussed here.
1. System Configuration 1. Assemble the microfluidic chip using world-to-chip connections on the fluidic breadboard, as described in Section 3. Make connections using tubing (such as 1/16" outer diameter fluoropolymer tubing) to a fluid pump and collection vials. Mount the breadboard assembly on the stage of a microscope capable of fluorescence imaging equipped with a CCD camera. 2. In the event of clogs or blockages in one of the outlets, flush the system while plugging the clear outlet to clear the blockage. If this is unsuccessful, reverse the flow direction during flushing, optionally applying rapid pulses of reverse flow (using a manuallyactuated syringe). Finally, if the blockage still cannot be removed, replace the tubing or chip, as necessary.
3. Frequency Scan Setup for Acoustic Focusing 1. Fill the bypass channel (see Figure 1 ) with fluid such as deionized water, ethanol, or phosphate buffered saline (PBS) by manual injection with a syringe. Note that this fluid does not come into contact with the sample being processed. The details of adjusting node position using different bypass fluids are described elsewhere 16, 17 . In brief, if the node needs to be closer to the dividing wall, use a lower-density bypass fluid, such as ethanol; for node placement closer to the input sample stream, choose a denser fluid, such as a glycerol solution. 2. Make a bead solution of approximately 0.01% (w/v) 5-8 µm fluorescent polymer beads suspended in a buffer such as PBS with 0.05% Tween-20 and fill the sample inlet syringe with the bead solution. Fill the buffer inlet syringe with the same buffer (this does not need to be the same fluid as in the bypass channel). Note that in general, the buffer is chosen to suit the application (see Step 5.1). 3. With the fluidic breadboard on the microscope stage, focus approximately halfway into the depth of the channel at a straight channel region just before the outlet with both channels (separation and bypass) in the field of view. An additional oblique-angle external light source may be required to make the channel walls visible, for successful post-processing of image data.
4. Automated Frequency Scan and Image Capture 1. Make electrical connections using shielded cables (e.g., RG-58 equipped with BNC connectors) to a function generator with radio frequency (RF) amplifier to deliver the excitation signal to the piezo transducer. Optionally, connect an oscilloscope to the output of the function generator for monitoring the actual voltage applied to the transducer. 2. Turn on the cooling fan, and set the function generator such that the output of the RF amplifier to the piezo transducer is in the range of 12-25 volts peak-to-peak (V pp ). 3. Set both syringes to the same flow rate between 50 and 200 µl/min. Using a single syringe pump to drive both syringes with the same motor is recommended to minimize perturbations to the flow. 4. Perform a frequency scan procedure by specifying the start and end frequencies, the step size between frequency values, and the piezo drive voltage using a laboratory automation toolkit such as National Instruments LabVIEW. 5. At each frequency step, apply the voltage for 15 sec to allow the system to equilibrate, then capture 10 images of beads flowing through the chip for subsequent analysis (exposure times between 10 and 100 msec are recommended). 6. Between each applied frequency step, turn off the voltage for approximately 20 sec to let the beads redistribute uniformly across the channel and remove bias in focusing from the previously applied frequency step. 1. System Configuration and Sample Preparation 1. Connect the microfluidic chip to the syringe pump, computer-controlled multi-port selection valves, PC-interfaced flow meters, and tubing, as shown in Figure 4 . This configuration enables automated processing of samples through the microfluidic separation chip, as well as automated cleaning steps between experiments to remove cross-contamination and sample carry-over. 2. Use a sample buffer suitable for the cells or particles to be separated, or as required by the analysis assay to be used after separation.
As in Step 4.3.2, the recovery buffer (but not necessarily the bypass fluid) must match the sample fluid. NOTE: Any aqueous buffers typically used with biological samples (e.g., PBS) have acoustic properties similar to water and will not appreciably change the performance of the acoustic device. The use of sample fluids with density and viscosity significantly different from water is possible, but only recommended for operators with significant acoustophoresis experience. 2. Separation Procedure 1. Pre-run state. Prior to running the separation, ensure that the cleaning reagent reservoirs (bleach, ethanol, buffer) have sufficient fluid, the waste reservoirs are not full, and the fluid lines are primed (i.e., filled with solution). If the latter condition is uncertain, or if the system is being run for the first time after idling (e.g., the first time on a given day), run an automated cleaning procedure (see Step 5.3 below). Set Valves 3 and 4 at the chip outlets to flow to waste reservoirs initially. 2. Turn on the cooling fan, and set the function generator at the resonant frequency for the acoustic chip being used, as determined in step 4.5. Adjust the voltage set point on the function generator so that the RF amplifier outputs between 12 and 25 V pp , as appropriate for the desired separation. 3. Connect the Sample Input Vial, Buffer Input Vial, and appropriate collection vials to the system. Just before attaching the Sample Input Vial to its pickup tubing, vortex the vial briefly to re-suspend any particles that may have settled. Then, attach the vial and initiate the separation routine without delay. CAUTION: If the sample to be processed contains potentially infectious agents, the vials should be of a screw-top type, to maintain a sealed system and prevent sample aerosolization. In addition, when working with biohazardous materials, handle all vials and tubing while wearing the necessary protective equipment and using the required hazard controls and procedures for the Biological Risk Group and Biosafety Level appropriate to the material. Consult institutional policies and protocols in case of any uncertainty. 4. Use a program in a laboratory automation toolkit to control the valves, flow sensors and pump to carry out the fully-automatic separation routine. NOTE: The routine switches the valves, actuates syringe pump withdrawal and infusion, and monitors flow sensor data for correctly timing the collection of output sample fractions. The major steps are summarized below in 5.2. Figure 5a . A typical loading sequence for processing a 250-µl sample is to withdraw 25 µl of air at 50 µl/min, then 250 µl of sample at 200 µl/min, followed by 35 µl of leading buffer at 200 µl/min, and finally another 25 µl of air at 50 µl/min. NOTE: All volumes and flow rates are user-selectable. Note that this loading sequence is in reverse order of how the fluid plugs will flow through the separation device. 3. Begin sample infusion. Set the syringe pumps to infuse the loaded fluid plugs at the desired rate (typically 100 µl/min). Monitor the flow rates at the SPO and LPO with flow sensors to ensure that flow is steady and at the ratio determined in Step 4.1, and that clogging has not occurred.
After identifying chips that are effective separators, they are incorporated into the system depicted in Figure 4 . Total system swept volume is minimized by using tubing with 0.01" inner diameter along the main flow path (blue lines). Figure 5A illustrates the make-up of a typical sample plug infused through the system. A small amount of "leading buffer" (~35 µl) is required to precede the sample in the flow to eliminate flow fluctuations while the sample is moving through the separation chip. Figure 5B shows flow data resulting from a successful automated acoustic separation experiment. Key features of a successful run include: (1) a transient increase in flow rate in both the LPO and SPO as pressure builds and fluid begins to flow through the system, (2) a sharp spike indicating the passage of an air bubble (the inset shows an expanded profile of a single bubble), which should reach the SPO before the LPO due to the unequal flow from the two outlets, (3) stable flow through both outlets between the two air bubbles as the sample moves through the system, and (4) a gradual decrease in flow rate in both outlets after the full sample volume is delivered to the system. Problematic runs are immediately apparent from flow profiles similar to Figure 5C , where it appears that the SPO became clogged after approximately 220 seconds. In this case, a cleaning procedure similar to that described in Step 5.3 should be run to unclog the channel. shows compiled separation results using various polystyrene particle sizes and piezo driving voltages that demonstrate the operating parameters necessary for efficient separation. In general, higher voltages (i.e., greater acoustic forces) are required to extract smaller particles, as expected. Drive voltages cannot be indefinitely increased, however, due to greater heat dissipation and increasing effects of acoustic streaming. 13 The plot serves as a general guide for particle separation-particle sizes that show significantly different recovery at a specific drive voltage (e.g., 10-and 2-µm particles at 8.8 V pp ) will separate well. Generally, particle populations with a large size difference, such as viruses (~100 nm) and cells (~10 µm) can be separated rapidly and efficiently, as can cells of different sizes (e.g., 6-8 µm discoidal erythrocytes and 8-15 µm leukocytes). The specific conditions required to work with other cell types must be empirically determined, as cell shape, density and compressibility affect its acoustic contrast, in addition to cell size. To this end, the procedures in Step 4 are useful for determining usable separation conditions for any new cell or particle type, and not only for assessing the quality of a particular acoustophoresis device. To demonstrate the utility of this platform for biological particle separation, we first used it to process well-characterized biological samples: human Raji cells (10 5 cells/ml, average diameter 8-10 µm 25 ) spiked with dengue virus (DENV, 10 5 pfu/ml, approximate diameter 50 nm 26 ). Figure 7A shows the percentage of Raji cells and DENV collected in both the SPO and LPO (defined as the fraction of each particle type collected from each outlet compared with the total amount of each particle collected from the chip). The experiment was repeated in triplicate, and Raji cells were quantified using a Coulter counter, while DENV was quantified using a reverse-transcription quantitative polymerase chain reaction (RT-qPCR).
Next, the performance of the system was tested in a scenario that is more realistic for processing clinical samples, in which the exact physical characteristics of the particles may be unknown, and the available sample quantities are lower. Here, we assessed separation of the recentlyidentified golden gate virus (GGV), a snake pathogen infecting boa constrictor kidney cells. 27 The size of the GGV virus particle has not yet been measured, but since GGV belongs to the Arenaviridae family, it is likely of a similar size, between 100 and 150 nm. 28 We processed samples with GGV spiked (10 4 pfu/ml) into Raji human cells (not an infection target for the virus), and boa kidney cells (infection target for GGV, approximate size 10 µm 27 ), with both cell types at 10 4 cells/ml. As these samples were available in low quantities, separation results from only one experimental run are reported in this work. Figure 7B shows the percentage of Raji cells, Boa cells, and GGV collected from the SPO and LPO. Cells were quantified in these experiments by counting on a hemacytometer and viruses were quantified by RT-qPCR.
Discussion
This protocol presents the system-level integration of microfluidic devices to macroscale equipment to perform automated biological sample processing. The modularity of this platform allows it to be adaptable to any continuous flow device, and, as an example, the presented protocol focuses on characterizing and optimizing the performance of an acoustofluidic particle separation device. Three major advantages of this protocol are highlighted: (i) modularity and chip-to-world interfacing, (ii) robust characterization of device performance, and (iii) automated processing of precisely metered sample volumes for particle separation.
i. Modularity and chip-to-world interfacing
As shown in Figure 2 , the microfluidic chip is mounted on a custom breadboard to easily fit onto a microscope stage for direct observation. The breadboard contains #6-40 UNF threaded holes on a 5 mm-pitch grid, enabling the chip to be secured, and fluid connections to be made. The fluid connections are PEEK tubes with machined ends, which seal against the fluidic chip with a rubber face-sealing gasket and a stainless steel collar. This interface scheme makes for easy chip replacement and rapid device redesign, requiring few or no changes to other system components, provided chip footprints conform to the grid format. For example, we have used this platform with microfluidic chips for continuousflow electrophoresis, thermal cell lysis, 29 rapid mixing of reagents for chemical synthesis, and single-cell capture and interrogation.
ii. Robust characterization of device performance
In order to optimize the performance of any microfluidic separation device, its operation must first be thoroughly characterized. The system described here supports the development of rapid and automated protocols to do this. For the specific example of acoustic focusing devices, the focusing quality, operating frequency, and position of focused particles in the microfluidic channel must be measured for each individual device. These measurements require sweeping through a range of piezoceramic drive frequencies, voltages and flow rates, to identify the optimal parameter combinations for high-quality separation. The presented protocol automatically varies these tunable parameters and captures the relevant data-i.e., fluorescent images of particles flowing in the channel that are post-processed to generate the required measurements of particle focusing quality, frequency, and position (Figure 3 ).
Full characterization of acoustic device performance requires repeating Steps 4.4 and 4.5 as needed under different experimental conditions. For instance, the absolute focusing position of a chip is found by running the frequency scan at relatively low flow rates and high voltages to ensure complete migration to the node location. Additionally, such frequency scans can assess the quality of device assembly (when run with polystyrene beads of known size), or to determine how a previously-unknown particle type will behave in the system (after a chip has been characterized with beads). A chip with good energy transfer from the piezoceramic to the microfluidic channel will result in tight focusing at high flow rates (>1 ml/min) and low voltages (12-15 V pp ), while those with poor energy transfer will not focus even at low flow rates (<100 µl/min) and high voltages (>20 V pp ). We have found that intimate contact between the microfluidic chip and the piezoceramic is critical for efficient energy transfer into the fluid. Further investigation of the optimal method of bonding the microfluidic chip and the piezoceramic will enable reliable production of high-performance devices.
Finally, a complete picture of an acoustophoretic device's operation can be obtained by combining the image-based frequency scan measurements of Step 4 (and Figure 3) with particle counts collected from the SPO and LPO as functions of the relevant operating parameters, from separation experiments carried out with microspheres, as described in Step 5. As shown in Figure 6 , such a series of automated experiments can rapidly characterize an individual device's performance and tunability, informing the user of the optimal parameter space to operate the device for particle separation.
iii. Automated small-sample processing for particle separation
For successful and accurate microfluidic chip-based sample processing, it is critical to reliably and precisely meter, load, deliver, and collect the volumes of fluid as they pass through. This precision is especially important when the sample volume is small (~0.1-1 ml), which is common in clinical or research laboratory settings. 30 Precise sample handling is challenging in traditional microfluidic experiments that employ manual withdrawal of the sample into a syringe and infusion into a device with no feedback of when the sample has been separated and when it should be collected. The presented protocol employs automated sample coil loading and dispensing coupled with real-time feedback from flow sensors to enable reproducible separations of small sample volumes. Figure 5 shows the flow profiles measured at the SPO and LPO from a typical separation experiment. First, leading buffer of at least 35 µl is loaded to ensure stable flow before the sample reaches the acoustic chip. Sample volumes less than 100 µl are not recommended for this system configuration, because sample dilution due to the leading buffer becomes excessive. A plug of air is used at the beginning of the injection before the leading buffer to separate the sample plug from the fluid that follows, preventing mixing and dilution of sample and serving as an indicator to the flow sensors. After an initial transient as fluid begins moving through the system, sharp spike signals in both outlets indicate the passage of the first air bubble. These transients are followed by a long period of stable flow as the sample flows through the system, then another spike when the second air bubble passes, and finally an eventual decrease in flow rate to zero after the syringe pump stops.
The passage of the air plugs through the flow sensors is used as trigger points to switch the valves to start and stop sample collection, thus minimizing lost sample and dilution by non-sample fluid volumes. Closed-loop metering of processed sample volumes eliminates the need to re-program these values prior to the start of the experiment each time the input sample is changed. This feature is particularly important when sample volume is limited, for example in the case of many clinical samples. Real-time flow monitoring also assists in troubleshooting; a poor run (e.g., a clog forming in one of the outlets) is immediately evident from the resultant flow profiles, as in Figure 5b .
To demonstrate the flexibility and effectiveness of acoustofluidic separation using the presented system architecture, purified DENV and GGV virus stocks were spiked into cell stocks and separated by processing through the microfluidic chip. Figure 7a shows that Raji cells were wellseparated from viruses, as 97% of Raji cells exiting the chip were found to be in the LPO, thereby leaving a highly enriched sample of DENV in the SPO. In comparison, the efficiency of DENV separation was lower, with 70% of DENV exiting the chip found in the SPO. This can be attributed to slight convective mixing induced by the turns of the separation channel, but more likely to some DENV particles migrating along with the Raji cells into the LPO. Cells migrating laterally across streamlines drag some fluid with them, even at low Reynolds number. By this mechanism, as well as nonspecific surface adsorption, viral particles transfer into the LPO. Nevertheless, the highly enriched sample of DENV in the SPO is a significant benefit, for instance when de novo sequencing is used to detect and identify viruses.
Figure 7b
shows that in one experimental run, only about 70% of Boa cells exiting the chip were found in the LPO, compared with nearly 100% separation efficiency for Raji cells. The difference in separation performance between the two cell types may be attributable to a smaller average size or a lower density of Boa cells as compared to Raji cells, therefore resulting in smaller acoustic forces. To confirm or refute these suppositions, the size, density and morphology of Boa cells in suspension (which normally grow adherent) of Boa cells must be accurately measured, an effort for further investigation. In the same experiments, similarly to the experiments with DENV, the bulk of the recovered GGV exited from the SPO, indicating an enrichment of the viral fraction.
The presented data highlight the inherent challenges of engineering broadly-applicable platforms for processing a variety of biological samples. Importantly, the biological interactions can begin to play as great a role as the physical and mechanical effects. However, these preliminary experiments also demonstrate the power and promise of using this system architecture for sample processing in clinical and research applications. As a robust, well-characterized engineered system, this platform provides the capability to seek answers to new scientific questions.
Disclosures
The authors have nothing to disclose.
